| pubmed-article:3653224 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3653224 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:3653224 | lifeskim:mentions | umls-concept:C0059735 | lld:lifeskim |
| pubmed-article:3653224 | lifeskim:mentions | umls-concept:C0023896 | lld:lifeskim |
| pubmed-article:3653224 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:3653224 | lifeskim:mentions | umls-concept:C0059734 | lld:lifeskim |
| pubmed-article:3653224 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:3653224 | pubmed:dateCreated | 1987-11-17 | lld:pubmed |
| pubmed-article:3653224 | pubmed:abstractText | We have investigated the effect of alcoholic liver disease (ALD) on the metabolism of 7-ethoxycoumarin 0-deethylase in human liver microsomes. EROD activity was significantly reduced in tissue from ALD patients who smoked, compared to smoking controls. A similar trend was seen in non-smokers. These results have implications for the metabolism of environmental carcinogens. | lld:pubmed |
| pubmed-article:3653224 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3653224 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3653224 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3653224 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3653224 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3653224 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3653224 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3653224 | pubmed:issn | 0031-6970 | lld:pubmed |
| pubmed-article:3653224 | pubmed:author | pubmed-author:RawlinsM DMD | lld:pubmed |
| pubmed-article:3653224 | pubmed:author | pubmed-author:WilliamsF MFM | lld:pubmed |
| pubmed-article:3653224 | pubmed:author | pubmed-author:JamesO FOF | lld:pubmed |
| pubmed-article:3653224 | pubmed:author | pubmed-author:MutchEE | lld:pubmed |
| pubmed-article:3653224 | pubmed:author | pubmed-author:WoodhouseK... | lld:pubmed |
| pubmed-article:3653224 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3653224 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:3653224 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3653224 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3653224 | pubmed:pagination | 559-62 | lld:pubmed |
| pubmed-article:3653224 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:3653224 | pubmed:meshHeading | pubmed-meshheading:3653224-... | lld:pubmed |
| pubmed-article:3653224 | pubmed:meshHeading | pubmed-meshheading:3653224-... | lld:pubmed |
| pubmed-article:3653224 | pubmed:meshHeading | pubmed-meshheading:3653224-... | lld:pubmed |
| pubmed-article:3653224 | pubmed:meshHeading | pubmed-meshheading:3653224-... | lld:pubmed |
| pubmed-article:3653224 | pubmed:meshHeading | pubmed-meshheading:3653224-... | lld:pubmed |
| pubmed-article:3653224 | pubmed:meshHeading | pubmed-meshheading:3653224-... | lld:pubmed |
| pubmed-article:3653224 | pubmed:meshHeading | pubmed-meshheading:3653224-... | lld:pubmed |
| pubmed-article:3653224 | pubmed:meshHeading | pubmed-meshheading:3653224-... | lld:pubmed |
| pubmed-article:3653224 | pubmed:meshHeading | pubmed-meshheading:3653224-... | lld:pubmed |
| pubmed-article:3653224 | pubmed:meshHeading | pubmed-meshheading:3653224-... | lld:pubmed |
| pubmed-article:3653224 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3653224 | pubmed:articleTitle | 7-Ethoxyresorufin deethylase (EROD) in human liver--the effect of alcoholic liver disease. | lld:pubmed |
| pubmed-article:3653224 | pubmed:affiliation | Department of Medicine (Geriatrics), University of Newcastle upon Tyne, U.K. | lld:pubmed |
| pubmed-article:3653224 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3653224 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3653224 | lld:pubmed |
